Abstract
Poor prognosis of patients suffering from malignant gliomas has not changed in the last decade. The 5-year survival rates are still disappointing (less than 5%). Chemotherapy is given either for adjuvant treatment or in case of relapse. The nitrosoureas playa leading role in chemotherapy of gliomas. They are of small molecular size, lipid soluble and are bound only minimally to protein, which enables them to cross the intact blood-brain-barrier (“bbb”). A similar penetration is known for Procarbazine (PCB). Other cytostatic agents e.g. Dacarbazine (DTIC), Ifosfamide (IFO) and Teniposide (VM-26) do not cross the “bbb”. Various degrees of alterations in the “bbb” are known in patients suffering from brain tumours. This fact makes the prediction of the success following treatment with a given cytostatic drug difficult. Clinicians have looked for experimental models which enable valid preclinical screening of cytostatic drugs. One of the best models for this purpose is the athymic nude mouse. Subcutaneously implanted human gliomas can be directly observed for their response to different chemotherapies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bloom (H.J.G.): Intracranial tumours: Response and resistance to therapeutic endeavours, 1970–1980. Int. J. Radiation Oncol. Biol. Phys. 8: 1083–1113.
Bradley (N.J.), Bloom (H.J.G.), Davies (A.J.S.) and Swift (S.M.): Growth of human gliomas in immune- deficient mice: A possible model for preclinical therapy studies. Br. J. Cancer 38: 263–272.
Harada (K.), Kiya (K.), Okamoto (H.), Uozumi (T.): Comparative studies of the anti-tumor effect of nitrosoureas, ACNU and MCNU, on experimental brain tumors. In: Proceedings 13th International Cancer Congress, Sept. 8–15, 1982, Seattle, Washington USA, No. 3145.
Hori (M.), Nakagawa (H.), Hasagawa (H.), Mogami (H.), Hayakawa (T.), Nakata (T.): ACNU, a new nitrosourea compound, in the treatment of gliomas. Gann-t-Kagakuryoho, 1978, 5: 773–778.
Horten (B.C.), Basler (G.A.), Shapiro (W.R.): Xenograft of human malignant glial tumors into brain of nude mice. J. Neuropathol. Exp. Neurol., 1981, 40: 493–511.
Houchens (D.P.), Ovejera (A.A.), Riblet (S.M.), Slagel (D.E.): Human brain tumor xenografts in nude mice as a chemotherapy model. Eur. J. Cancer. Clin. Oncol., 1985, 19: 799–805.
Rana (M.W.), Pinkerton (H.), Thornton (H.), Nagy (D.): Heterotransplantation of human glioblastoma multiforme and meningioma to nude mice. Proc. Soc. Exp. Biol. and Med., 1977, 155: 85–88.
Schold (S.C.), Jr., Friedman (H.S.): Human brain tumor xenografts. Prog. Exp. Tumor Res., 1984, 28: 18–31.
Shapiro (W.R.), Basler (G.A.), Chernik (N.L.), Posner (J.B.): Human brain tumor transplantation into nude mice. J. Natl. Cancer Inst., 1979, 62: 447–453.
Shapiro (W.R.), Basler (G.A.): Chemotherapy of human brain tumors transplanted into nude mice, in Paoletti, Walker, Butti, Knerich, Multidisciplinary aspects of brain tumor therapy, pp. 309–316 (Elsevier, Amsterdam, 1979).
Yamashita (J.), Handa (H.), Tokuriki (Y.), Ha (Y.S.), Otsuka (S.I.): Intra-arterial ACNU therapy for malignant brain tumors. Experimental studies and preliminary clinical results. J. Neurosurg., 1983, 59: 424–430.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Martinus Nijhoff Publishers, Dordrecht
About this chapter
Cite this chapter
Budach, V., Bamberg, M., Stuschke, M., Czeglarski, G., Duwe, S. (1987). Chemosensitivity Studies on Human Gliomas in Nude Mice Preliminary Results. In: Chatel, M., Darcel, F., Pecker, J. (eds) Brain Oncology Biology, diagnosis and therapy. Developments in Oncology, vol 52. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-3347-7_67
Download citation
DOI: https://doi.org/10.1007/978-94-009-3347-7_67
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-8003-3
Online ISBN: 978-94-009-3347-7
eBook Packages: Springer Book Archive